Ruizhe Zhao

发表

BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people

C. Qin, Yun Liu, Yongsheng Pan, 2017, Oncotarget.

Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population

C. Qin, C. Yin, Ming Yang, 2015, PloS one.

Role of genetic mutations in folate-related enzyme genes on Male Infertility

J. Li, Kang Liu, Zengjun Wang, 2015, Scientific Reports.

The Association between Abnormal Long Noncoding RNA MALAT-1 Expression and Cancer Lymph Node Metastasis: A Meta-Analysis

P. Shao, C. Qin, Yongsheng Pan, 2016, BioMed research international.

GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy

C. Qin, C. Yin, X. Yang, 2015, Scientific Reports.

miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.

J. Li, P. Shao, Pu Li, 2015, DNA and cell biology.

Meta-Analysis Reveals a Lack of Association between UGT2B17 Deletion Polymorphism and Tumor Susceptibility

P. Shao, C. Qin, Q. Cao, 2014, PloS one.

XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C

C. Qin, C. Yin, X. Yang, 2015, Tumor Biology.

Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.

C. Qin, C. Yin, X. Yang, 2014, International journal of clinical and experimental medicine.

Original Article Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract

C. Qin, C. Yin, X. Yang, 2014 .

Developing a Follow-Up Strategy for Patients with PSA Ranging from 4 to 10 ng/ml via a New Model to Reduce Unnecessary Prostate Biopsies

P. Shao, C. Qin, C. Yin, 2014, PloS one.

Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.

Zengjun Wang, G. Cheng, L. Hua, 2021, International immunopharmacology.